Skip to main content
Clinical Trials/JPRN-UMIN000021109
JPRN-UMIN000021109CompletedPhase 3

Preventive effect of Sivelestat Na Hydrate on postoperative acute exacerbation of idiopathic interstitial pneumonia in the patient with lung cancer - Preventive effect of Sivelestat Na Hydrate on postoperative acute exacerbation of idiopathic interstitial pneumonia in the patient with lung cancer (Sivelestat trial)

Japanese Northern East Area Thoracic Surgery Study Group (JNETS)0 sites120 target enrollmentStarted: February 19, 2016Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
25years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1) With serious liver disorder (2) With serious renal dysfunction (3) With bleeding tentency (4) Patients registered in clinical trial of other drugs

Investigators

Sponsor
Japanese Northern East Area Thoracic Surgery Study Group (JNETS)

Similar Trials